China Oncology or Cancer Drugs Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Oncology or Cancer Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • AstraZeneca PLC

    • Bristol-Myers Squibb Company

    • Pfizer Inc

    • Merck & Co, Inc

    • Novartis AG

    • AbbVie Inc

    • Amgen

    By Type:

    • Immunotherapy (Biologic Therapy)

    • Targeted Therapy

    • Hormonal Therapy

    • Chemotherapy

    By Application:

    • Retail Pharmacies

    • Others

    • Hospital Pharmacies

    • Online Pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Oncology or Cancer Drugs Market Overview 2018-2029

    • 1.1 China Oncology or Cancer Drugs Industry Development Overview

    • 1.2 China Oncology or Cancer Drugs Industry Development History

    • 1.3 China Oncology or Cancer Drugs Industry Market Size (2018-2029)

    • 1.4 China Oncology or Cancer Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Oncology or Cancer Drugs Production Volume, Production Value and Growth Rate of Immunotherapy (Biologic Therapy) (2018-2029)

      • 1.4.2 China Oncology or Cancer Drugs Production Volume, Production Value and Growth Rate of Targeted Therapy (2018-2029)

      • 1.4.3 China Oncology or Cancer Drugs Production Volume, Production Value and Growth Rate of Hormonal Therapy (2018-2029)

      • 1.4.4 China Oncology or Cancer Drugs Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)

    • 1.5 China Oncology or Cancer Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Oncology or Cancer Drugs Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

      • 1.5.2 China Oncology or Cancer Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Oncology or Cancer Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

      • 1.5.4 China Oncology or Cancer Drugs Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

    • 1.6 China Oncology or Cancer Drugs Market Analysis by Region

      • 1.6.1 North China Oncology or Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Oncology or Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Oncology or Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Oncology or Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Oncology or Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Oncology or Cancer Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Oncology or Cancer Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Oncology or Cancer Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Oncology or Cancer Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Oncology or Cancer Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Oncology or Cancer Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Oncology or Cancer Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Oncology or Cancer Drugs Industry Development

    Chapter 3 Oncology or Cancer DrugsIndustry Chain Analysis

    • 3.1 Oncology or Cancer Drugs Industry Chain

    • 3.2 Oncology or Cancer Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Oncology or Cancer Drugs Market

    • 3.3 Oncology or Cancer Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Oncology or Cancer Drugs Market

    Chapter 4 China Oncology or Cancer Drugs Market, by Type

    • 4.1 China Oncology or Cancer Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Oncology or Cancer Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Oncology or Cancer Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Oncology or Cancer Drugs Production Volume and Growth Rate of Immunotherapy (Biologic Therapy)

      • 4.5.2 China Oncology or Cancer Drugs Production Volume and Growth Rate of Targeted Therapy

      • 4.5.3 China Oncology or Cancer Drugs Production Volume and Growth Rate of Hormonal Therapy

      • 4.5.4 China Oncology or Cancer Drugs Production Volume and Growth Rate of Chemotherapy

    Chapter 5 China Oncology or Cancer Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Oncology or Cancer Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Oncology or Cancer Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Oncology or Cancer Drugs Market Size and Growth Rate of Retail Pharmacies

      • 5.5.2 China Oncology or Cancer Drugs Market Size and Growth Rate of Others

      • 5.5.3 China Oncology or Cancer Drugs Market Size and Growth Rate of Hospital Pharmacies

      • 5.5.4 China Oncology or Cancer Drugs Market Size and Growth Rate of Online Pharmacies

    Chapter 6 China Oncology or Cancer Drugs Market, by Region

    • 6.1 China Oncology or Cancer Drugs Production Volume and Production Value, by Region

    • 6.2 China Oncology or Cancer Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Oncology or Cancer Drugs Market Analysis

    • 7.1 North China Oncology or Cancer Drugs Market, by Type

    • 7.2 North China Oncology or Cancer Drugs Market, by Application

    Chapter 8 Central China Oncology or Cancer Drugs Market Analysis

    • 8.1 Central China Oncology or Cancer Drugs Market, by Type

    • 8.2 Central China Oncology or Cancer Drugs Market, by Application

    Chapter 9 South China Oncology or Cancer Drugs Market Analysis

    • 9.1 South China Oncology or Cancer Drugs Market, by Type

    • 9.2 South China Oncology or Cancer Drugs Market, by Application

    Chapter 10 East China Oncology or Cancer Drugs Market Analysis

    • 10.1 East China Oncology or Cancer Drugs Market, by Type

    • 10.2 East China Oncology or Cancer Drugs Market, by Application

    Chapter 11 Northeast China Oncology or Cancer Drugs Market Analysis

    • 11.1 Northeast China Oncology or Cancer Drugs Market, by Type

    • 11.2 Northeast China Oncology or Cancer Drugs Market, by Application

    Chapter 12 Southwest China Oncology or Cancer Drugs Market Analysis

    • 12.1 Southwest China Oncology or Cancer Drugs Market, by Type

    • 12.2 Southwest China Oncology or Cancer Drugs Market, by Application

    Chapter 13 Northwest China Oncology or Cancer Drugs Market Analysis

    • 13.1 Northwest China Oncology or Cancer Drugs Market, by Type

    • 13.2 Northwest China Oncology or Cancer Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 AstraZeneca PLC

        • 14.1.1 AstraZeneca PLC Company Profile

        • 14.1.2 AstraZeneca PLC Oncology or Cancer Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bristol-Myers Squibb Company

        • 14.2.1 Bristol-Myers Squibb Company Company Profile

        • 14.2.2 Bristol-Myers Squibb Company Oncology or Cancer Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Pfizer Inc

        • 14.3.1 Pfizer Inc Company Profile

        • 14.3.2 Pfizer Inc Oncology or Cancer Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Merck & Co, Inc

        • 14.4.1 Merck & Co, Inc Company Profile

        • 14.4.2 Merck & Co, Inc Oncology or Cancer Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Novartis AG

        • 14.5.1 Novartis AG Company Profile

        • 14.5.2 Novartis AG Oncology or Cancer Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 AbbVie Inc

        • 14.6.1 AbbVie Inc Company Profile

        • 14.6.2 AbbVie Inc Oncology or Cancer Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Amgen

        • 14.7.1 Amgen Company Profile

        • 14.7.2 Amgen Oncology or Cancer Drugs Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Oncology or Cancer Drugs Industry Research Conclusions

    • 15.2 Oncology or Cancer Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Oncology or Cancer Drugs Industry Market Size (2018-2029)

    • Figure China Oncology or Cancer Drugs Production Volume, Production Value and Growth Rate of Immunotherapy (Biologic Therapy) (2018-2029)

    • Figure China Oncology or Cancer Drugs Production Volume, Production Value and Growth Rate of Targeted Therapy (2018-2029)

    • Figure China Oncology or Cancer Drugs Production Volume, Production Value and Growth Rate of Hormonal Therapy (2018-2029)

    • Figure China Oncology or Cancer Drugs Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)

    • Figure China Oncology or Cancer Drugs Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • Figure China Oncology or Cancer Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Oncology or Cancer Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • Figure China Oncology or Cancer Drugs Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

    • Figure North China Oncology or Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Oncology or Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Oncology or Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Oncology or Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Oncology or Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Oncology or Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Oncology or Cancer Drugs Market Size and Growth Rate from 2018-2029

    • Figure Oncology or Cancer Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Oncology or Cancer Drugs Market Share by Type in 2018

    • Figure China Oncology or Cancer Drugs Market Share by Type in 2023

    • Figure China Oncology or Cancer Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Oncology or Cancer Drugs Production Volume and Growth Rate of Immunotherapy (Biologic Therapy) (2018-2023)

    • Figure China Oncology or Cancer Drugs Production Volume and Growth Rate of Targeted Therapy (2018-2023)

    • Figure China Oncology or Cancer Drugs Production Volume and Growth Rate of Hormonal Therapy (2018-2023)

    • Figure China Oncology or Cancer Drugs Production Volume and Growth Rate of Chemotherapy (2018-2023)

    • Figure China Oncology or Cancer Drugs Market Share by Application in 2018

    • Figure China Oncology or Cancer Drugs Market Share by Application in 2023

    • Figure China Oncology or Cancer Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Oncology or Cancer Drugs Market Size and Growth Rate of Retail Pharmacies (2018-2023)

    • Figure China Oncology or Cancer Drugs Market Size and Growth Rate of Others (2018-2023)

    • Figure China Oncology or Cancer Drugs Market Size and Growth Rate of Hospital Pharmacies (2018-2023)

    • Figure China Oncology or Cancer Drugs Market Size and Growth Rate of Online Pharmacies (2018-2023)

    • Table China Oncology or Cancer Drugs Production Volume by Region (2018-2023)

    • Table China Oncology or Cancer Drugs Production Volume Share by Region (2018-2023)

    • Figure China Oncology or Cancer Drugs Production Volume Share by Region (2018-2023)

    • Table China Oncology or Cancer Drugs Production Value by Region (2018-2023)

    • Table China Oncology or Cancer Drugs Production Value Share by Region (2018-2023)

    • Figure China Oncology or Cancer Drugs Production Value Share by Region (2018-2023)

    • Table China Oncology or Cancer Drugs Sales Volume by Region (2018-2023)

    • Table China Oncology or Cancer Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Oncology or Cancer Drugs Sales Volume Share by Region (2018-2023)

    • Table China Oncology or Cancer Drugs Sales Value by Region (2018-2023)

    • Table China Oncology or Cancer Drugs Sales Value Share by Region (2018-2023)

    • Figure China Oncology or Cancer Drugs Sales Value Share by Region (2018-2023)

    • Table North China Oncology or Cancer Drugs Production Volume by Type (2018-2023)

    • Table North China Oncology or Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Oncology or Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table North China Oncology or Cancer Drugs Sales Volume by Application (2018-2023)

    • Table North China Oncology or Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Oncology or Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Oncology or Cancer Drugs Production Volume by Type (2018-2023)

    • Table Central China Oncology or Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Oncology or Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Oncology or Cancer Drugs Sales Volume by Application (2018-2023)

    • Table Central China Oncology or Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Oncology or Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Oncology or Cancer Drugs Production Volume by Type (2018-2023)

    • Table South China Oncology or Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Oncology or Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table South China Oncology or Cancer Drugs Sales Volume by Application (2018-2023)

    • Table South China Oncology or Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Oncology or Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Oncology or Cancer Drugs Production Volume by Type (2018-2023)

    • Table East China Oncology or Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Oncology or Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table East China Oncology or Cancer Drugs Sales Volume by Application (2018-2023)

    • Table East China Oncology or Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Oncology or Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Oncology or Cancer Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Oncology or Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Oncology or Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Oncology or Cancer Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Oncology or Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Oncology or Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Oncology or Cancer Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Oncology or Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Oncology or Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Oncology or Cancer Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Oncology or Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Oncology or Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Oncology or Cancer Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Oncology or Cancer Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Oncology or Cancer Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Oncology or Cancer Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Oncology or Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Oncology or Cancer Drugs Sales Volume Share by Application (2018-2023)

    • Table AstraZeneca PLC Company Profile

    • Table AstraZeneca PLC Oncology or Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Company Profile

    • Table Bristol-Myers Squibb Company Oncology or Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Oncology or Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc Oncology or Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Oncology or Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table AbbVie Inc Company Profile

    • Table AbbVie Inc Oncology or Cancer Drugs Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Oncology or Cancer Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.